Overview

Early Use of Corticosteroids in Non-critical Patients With COVID-19 Pneumonia

Status:
Terminated
Trial end date:
2021-01-30
Target enrollment:
Participant gender:
Summary
Steroids has shown benefits in COVID19 patients in observational studies. We hypothesized that early use of corticosteroids, low dose, in mild disease, can decrease progression to respiratory failure and death.
Phase:
Phase 3
Details
Lead Sponsor:
University of Chile
Collaborator:
Paulette Andino Sarmiento
Treatments:
Prednisone